Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:50 PM

Applied DNA Sciences Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
6.43M 7.15M 15.22M 6.55M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
750K 750K 99K 95.04K
Receivables
362.01K 255.5K 3.07M 2.8M
Inventory
438.59K 330.03K 602.24K 1.37M
Other Current Assets
815.97K 389.24K 1.06M 568.88K
Total Current Assets
8.05M 8.13M 19.94M 11.3M
Property-Plant & Equipment
1.29M 2.08M 2.22M 3.02M
Goodwill & Intangibles
2.7M 2.7M n/a n/a
Total Long-Term Assets
4.74M 5.53M 2.32M 3.12M
Total Assets
12.79M 13.65M 22.27M 14.42M
Account Payables
1.17M 1.07M 1.74M 1.36M
Deferred Revenue
58.78K 76.44K 563.56K 281K
Short-Term Debt
545.91K n/a n/a n/a
Other Current Liabilities
118.42K 59.99K 1.46M 655.24K
Total Current Liabilities
2.4M 2.85M 4.19M 3.27M
Long-Term Debt
193.25K 739.16K n/a n/a
Other Long-Term Liabilities
351.47K 4.32M 5.17M 31.47K
Total Long-Term Liabilities
1.42M 5.93M 5.17M 31.47K
Total Liabilities
3.82M 8.78M 9.36M 3.3M
Total Debt
739.16K 1.24M n/a n/a
Common Stock
10.31K 13.66K 12.91K 7.49K
Retained Earnings
-309.67M -302.45M -292.5M -284.12M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
9.14M 4.95M 12.91M 11.11M
Total Investments
n/a 750K n/a n/a